The Clinical Trials Company
- Date of Transaction: Dec 2019
- Acquirer: Veristat
- Service: M&A
- Sector: Healthcare
“We’re delighted to have assisted the shareholders of The Clinical Trial Company in securing a successful exit to Veristat, a US based full service CRO. Veristat are a great fit and are well placed to build on the success of the business to date”
Alpha Helix Corporate Finance (AHCF) is pleased to announce the sale of The Clinical Trial Company to Veristat LLC.
Formed in 2002, TCTC Group is a privately owned full-service clinical research provider, headquartered in the UK with regional offices across Europe, North America, Asia and Australia.
TCTC has experience across a wide range of therapeutic areas including small molecule pharmaceuticals, biologics and medical devices. The company has extensive expertise in advanced therapies such as cell and gene therapy, the development of first in class products, and the Central Nervous System (CNS)
Veristat is a scientifically oriented full-service clinical research organization (CRO) that partners with pharmaceutical, biotechnology, and medical device firms to advance their therapies throughout the entire clinical development and regulatory submission process.
Welcome to Alpha Helix
We are pleased to announce that on 12th March of this year, Gordon Hamilton led the MBO of Nexus Corporate Finance (NCF), therefore we have re-branded as Alpha Helix Corporate Finance (AHCF).
The team will remain unchanged and will continue to provide independent advice to exciting and fast-growing UK SMEs in the Healthcare sector.